{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:57:51Z","timestamp":1790063871687,"version":"4.0.1"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s40264-022-01257-1","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T13:03:07Z","timestamp":1671541387000},"page":"1-17","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Should Antidepressants be Avoided in Pregnancy?"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4530-7933","authenticated-orcid":false,"given":"Frank M. C.","family":"Besag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1983-3531","authenticated-orcid":false,"given":"Michael J.","family":"Vasey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,20]]},"reference":[{"key":"1257_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069637","volume":"8","author":"AJ Ferrari","year":"2013","unstructured":"Ferrari AJ, Charlson FJ, Norman RE, Flaxman AD, Patten SB, Vos T, et al. The epidemiological modelling of major depressive disorder: application for the global burden of disease study 2010. PLoS ONE. 2013;8: e69637.","journal-title":"PLoS ONE"},{"key":"1257_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1136\/jech.2005.039370","volume":"60","author":"JW Rich-Edwards","year":"2006","unstructured":"Rich-Edwards JW, Kleinman K, Abrams A, Harlow BL, McLaughlin TJ, Joffe H, et al. Sociodemographic predictors of antenatal and postpartum depressive symptoms among women in a medical group practice. J Epidemiol Community Health. 2006;60:221.","journal-title":"J Epidemiol Community Health"},{"issue":"Suppl. 7","key":"1257_CR3","first-page":"9","volume":"63","author":"VK Burt","year":"2002","unstructured":"Burt VK, Stein K. Epidemiology of depression throughout the female life cycle. J Clin Psychiatry. 2002;63(Suppl. 7):9\u201315.","journal-title":"J Clin Psychiatry"},{"key":"1257_CR4","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1001\/jama.282.13.1264","volume":"282","author":"KL Wisner","year":"1999","unstructured":"Wisner KL, Gelenberg AJ, Leonard H, Zarin D, Frank E. Pharmacologic treatment of depression during pregnancy. JAMA. 1999;282:1264\u20139.","journal-title":"JAMA"},{"key":"1257_CR5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jad.2017.05.003","volume":"219","author":"CA Woody","year":"2017","unstructured":"Woody CA, Ferrari AJ, Siskind DJ, Whiteford HA, Harris MG. A systematic review and meta-regression of the prevalence and incidence of perinatal depression. J Affect Disord. 2017;219:86\u201392.","journal-title":"J Affect Disord"},{"key":"1257_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1067\/mob.2003.336","volume":"189","author":"L Andersson","year":"2003","unstructured":"Andersson L, Sundstr\u00f6m-Poromaa I, Bixo M, Wulff M, Bondestam K, \u00c5str\u00f6m M. Point prevalence of psychiatric disorders during the second trimester of pregnancy: a population-based study. Am J Obstet Gynecol. 2003;189:148\u201354.","journal-title":"Am J Obstet Gynecol"},{"key":"1257_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1089\/154099903765448880","volume":"12","author":"SM Marcus","year":"2003","unstructured":"Marcus SM, Flynn HA, Blow FC, Barry KL. Depressive symptoms among pregnant women screened in obstetrics settings. J Womens Health. 2003;12:373\u201380.","journal-title":"J Womens Health"},{"key":"1257_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S2215-0366(16)00003-1","volume":"3","author":"H Khalifeh","year":"2016","unstructured":"Khalifeh H, Hunt IM, Appleby L, Howard LM. Suicide in perinatal and non-perinatal women in contact with psychiatric services: 15 year findings from a UK national inquiry. Lancet Psychiatry. 2016;3:233\u201342.","journal-title":"Lancet Psychiatry"},{"key":"1257_CR9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jama.295.5.499","volume":"295","author":"LS Cohen","year":"2006","unstructured":"Cohen LS, Altshuler LL, Harlow BL, Nonacs R, Newport DJ, Viguera AC, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006;295:499\u2013507.","journal-title":"JAMA"},{"key":"1257_CR10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.15288\/jsad.2008.69.500","volume":"69","author":"HA Flynn","year":"2008","unstructured":"Flynn HA, Chermack ST. Prenatal alcohol use: the role of lifetime problems with alcohol, drugs, depression, and violence. J Stud Alcohol Drugs. 2008;69:500\u20139.","journal-title":"J Stud Alcohol Drugs"},{"key":"1257_CR11","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1177\/070674370404901103","volume":"49","author":"L Bonari","year":"2004","unstructured":"Bonari L, Pinto N, Ahn E, Einarson A, Steiner M, Koren G. Perinatal risks of untreated depression during pregnancy. Can J Psychiatry. 2004;49:726\u201335.","journal-title":"Can J Psychiatry"},{"key":"1257_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119018","volume":"10","author":"R Hu","year":"2015","unstructured":"Hu R, Li Y, Zhang Z, Yan W. Antenatal depressive symptoms and the risk of preeclampsia or operative deliveries: a meta-analysis. PLoS ONE. 2015;10: e0119018.","journal-title":"PLoS ONE"},{"key":"1257_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0378-3782(02)00075-0","volume":"70","author":"EJH Mulder","year":"2002","unstructured":"Mulder EJH, Robles de Medina PG, Huizink AC, Van den Bergh BRH, Buitelaar JK, Visser GHA. Prenatal maternal stress: effects on pregnancy and the (unborn) child. Early Hum Dev. 2002;70:3\u201314.","journal-title":"Early Hum Dev"},{"key":"1257_CR14","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1001\/jamapsychiatry.2016.0934","volume":"73","author":"A Jarde","year":"2016","unstructured":"Jarde A, Morais M, Kingston D, Giallo R, MacQueen GM, Giglia L, et al. Neonatal outcomes in women with untreated antenatal depression compared with women without depression: a systematic review and meta-analysis. JAMA Psychiat. 2016;73:826\u201337.","journal-title":"JAMA Psychiat"},{"key":"1257_CR15","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.4088\/JCP.12r07968","volume":"74","author":"S Grigoriadis","year":"2013","unstructured":"Grigoriadis S, VonderPorten EH, Mamisashvili L, Tomlinson G, Dennis CL, Koren G, et al. The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry. 2013;74:e321\u201341.","journal-title":"J Clin Psychiatry"},{"key":"1257_CR16","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s12884-019-2572-4","volume":"19","author":"D Mongan","year":"2019","unstructured":"Mongan D, Lynch J, Hanna D, Shannon C, Hamilton S, Potter C, et al. Prevalence of self-reported mental disorders in pregnancy and associations with adverse neonatal outcomes: a population-based cross-sectional study. BMC Pregnancy Childbirth. 2019;19:412.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1257_CR17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neuroscience.2015.09.001","volume":"342","author":"S Gentile","year":"2017","unstructured":"Gentile S. Untreated depression during pregnancy: short- and long-term effects in offspring: a systematic review. Neuroscience. 2017;342:154\u201366.","journal-title":"Neuroscience"},{"key":"1257_CR18","first-page":"174550651984404","volume":"15","author":"J Slomian","year":"2019","unstructured":"Slomian J, Honvo G, Emonts P, Reginster J-Y, Bruy\u00e8re O. Consequences of maternal postpartum depression: a systematic review of maternal and infant outcomes. Womens Health. 2019;15:1745506519844044.","journal-title":"Womens Health"},{"key":"1257_CR19","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/da.22756","volume":"35","author":"S Tuovinen","year":"2018","unstructured":"Tuovinen S, Lahti-Pulkkinen M, Girchenko P, Lipsanen J, Lahti J, Heinonen K, et al. Maternal depressive symptoms during and after pregnancy and child developmental milestones. Depression Anxiety. 2018;35:732\u201341.","journal-title":"Depression Anxiety."},{"key":"1257_CR20","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2021.52","volume":"7","author":"RH Bind","year":"2021","unstructured":"Bind RH, Biaggi A, Bairead A, Du Preez A, Hazelgrove K, Waites F, et al. Mother-infant interaction in women with depression in pregnancy and in women with a history of depression: the Psychiatry Research and Motherhood - Depression (PRAM-D) study. BJPsych Open. 2021;7: e100.","journal-title":"BJPsych Open."},{"key":"1257_CR21","first-page":"B4916","volume":"61","author":"E Jimenez-Solem","year":"2014","unstructured":"Jimenez-Solem E. Exposure to antidepressants during pregnancy: prevalences and outcomes. Dan Med J. 2014;61:B4916.","journal-title":"Dan Med J"},{"key":"1257_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1176\/appi.ajp.2012.12040440","volume":"170","author":"LH Chaudron","year":"2013","unstructured":"Chaudron LH. Complex challenges in treating depression during pregnancy. Am J Psychiatry. 2013;170:12\u201320.","journal-title":"Am J Psychiatry"},{"key":"1257_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/0706743718802809","volume":"64","author":"K Adhikari","year":"2019","unstructured":"Adhikari K, Patten SB, Lee S, Metcalfe A. Adherence to and persistence with antidepressant medication during pregnancy: does it differ by the class of antidepressant medication prescribed? Can J Psychiatry. 2019;64:199\u2013208.","journal-title":"Can J Psychiatry"},{"key":"1257_CR24","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/01.AOG.0000116689.75396.5f","volume":"103","author":"HA Bennett","year":"2004","unstructured":"Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol. 2004;103:698\u2013709.","journal-title":"Obstet Gynecol"},{"key":"1257_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144474","volume":"10","author":"H Zoega","year":"2015","unstructured":"Zoega H, Kieler H, N\u00f8rgaard M, Furu K, Valdimarsdottir U, Brandt L, et al. Use of SSRI and SNRI antidepressants during pregnancy: a population-based study from Denmark, Iceland. Norway and Sweden PLoS One. 2015;10: e0144474.","journal-title":"Norway and Sweden. PLoS One."},{"key":"1257_CR26","unstructured":"National Institute for Health and Care Excellence (NICE). Depression: antenatal and postnatal: scenario: pregnant woman: on an antidepressant. 2022. Available from: https:\/\/cks.nice.org.uk\/topics\/depression-antenatal-postnatal\/management\/pregnant-on-an-antidepressant. [Accessed 29 Aug 2022]."},{"key":"1257_CR27","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.euroneuro.2019.06.007","volume":"29","author":"A B\u00e9rard","year":"2019","unstructured":"B\u00e9rard A, Sheehy O, Zhao J-P, Chambers C, Roth M, Bozzo P, et al. Impact of antidepressant use, discontinuation, and dosage modification on maternal depression during pregnancy. Eur Neuropsychopharmacol. 2019;29:803\u201312.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1257_CR28","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.3390\/ijerph19041973","volume":"19","author":"S Kittel-Schneider","year":"2022","unstructured":"Kittel-Schneider S, Felice E, Buhagiar R, Lambregtse-Van Den Berg M, Wilson CA, Baljak VB, et al. Treatment of peripartum depression with antidepressants and other psychotropic medications: a synthesis of clinical practice guidelines in Europe. Int J Environ Res Public Health. 2022;19:1973.","journal-title":"Int J Environ Res Public Health"},{"key":"1257_CR29","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1177\/0004867418762057","volume":"52","author":"NM Molenaar","year":"2018","unstructured":"Molenaar NM, Kamperman AM, Boyce P, Bergink V. Guidelines on treatment of perinatal depression with antidepressants: an international review. Aust N Z J Psychiatry. 2018;52:320\u20137.","journal-title":"Aust N Z J Psychiatry"},{"key":"1257_CR30","doi-asserted-by":"publisher","first-page":"979","DOI":"10.4088\/JCP.10m06090blu","volume":"72","author":"I Petersen","year":"2011","unstructured":"Petersen I, Gilbert RE, Evans SJ, Man SL, Nazareth I. Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from the Health Improvement Network. J Clin Psychiatry. 2011;72:979\u201385.","journal-title":"J Clin Psychiatry"},{"key":"1257_CR31","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/j.1471-0528.2002.01467.x","volume":"109","author":"T Heikkinen","year":"2002","unstructured":"Heikkinen T, Ekblad U, Laine K. Transplacental transfer of citalopram, fluoxetine and their primary demethylated metabolites in isolated perfused human placenta. BJOG. 2002;109:1003\u20138.","journal-title":"BJOG"},{"key":"1257_CR32","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s002130000597","volume":"153","author":"T Heikkinen","year":"2001","unstructured":"Heikkinen T, Ekblad U, Laine K. Transplacental transfer of amitriptyline and nortriptyline in isolated perfused human placenta. Psychopharmacology. 2001;153:450\u20134.","journal-title":"Psychopharmacology"},{"issue":"497","key":"1257_CR33","first-page":"e1","volume":"215","author":"VM Fokina","year":"2016","unstructured":"Fokina VM, West H, Oncken C, Clark SM, Ahmed MS, Hankins GDV, et al. Bupropion therapy during pregnancy: the drug and its major metabolites in umbilical cord plasma and amniotic fluid. Am J Obstet Gynecol. 2016;215(497):e1-7.","journal-title":"Am J Obstet Gynecol"},{"key":"1257_CR34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1176\/appi.ajp.163.1.145","volume":"163","author":"AM Loughhead","year":"2006","unstructured":"Loughhead AM, Fisher AD, Newport DJ, Ritchie JC, Owens MJ, DeVane CL, et al. Antidepressants in amniotic fluid: another route of fetal exposure. Am J Psychiatry. 2006;163:145\u20137.","journal-title":"Am J Psychiatry"},{"key":"1257_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.110228","volume":"107","author":"G Schoretsanitis","year":"2021","unstructured":"Schoretsanitis G, Westin AA, Stingl JC, Deligiannidis KM, Paulzen M, Spigset O. Antidepressant transfer into amniotic fluid, umbilical cord blood & breast milk: a systematic review & combined analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2021;107: 110228.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1257_CR36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1055\/s-0028-1103296","volume":"42","author":"J Rampono","year":"2009","unstructured":"Rampono J, Simmer K, Ilett KF, Hackett LP, Doherty DA, Elliot R, et al. Placental transfer of SSRI and SNRI antidepressants and effects on the neonate. Pharmacopsychiatry. 2009;42:95\u2013100.","journal-title":"Pharmacopsychiatry"},{"key":"1257_CR37","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1176\/appi.ajp.160.5.993","volume":"160","author":"V Hendrick","year":"2003","unstructured":"Hendrick V, Stowe ZN, Altshuler LL, Hwang S, Lee E, Haynes D. Placental passage of antidepressant medications. Am J Psychiatry. 2003;160:993\u20136.","journal-title":"Am J Psychiatry"},{"key":"1257_CR38","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.jadohealth.2012.04.009","volume":"51","author":"TF Oberlander","year":"2012","unstructured":"Oberlander TF. Fetal serotonin signaling: setting pathways for early childhood development and behavior. J Adolesc Health. 2012;51:S9-16.","journal-title":"J Adolesc Health"},{"key":"1257_CR39","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1002\/dneu.22185","volume":"74","author":"M-C Ko","year":"2014","unstructured":"Ko M-C, Lee LJ-H, Li Y, Lee L-J. Long-term consequences of neonatal fluoxetine exposure in adult rats. Dev Neurobiol. 2014;74:1038\u201351.","journal-title":"Dev Neurobiol."},{"key":"1257_CR40","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00213-011-2299-z","volume":"217","author":"JDA Olivier","year":"2011","unstructured":"Olivier JDA, Vall\u00e8s A, van Heesch F, Afrasiab-Middelman A, Roelofs JJPM, Jonkers M, et al. Fluoxetine administration to pregnant rats increases anxiety-related behavior in the offspring. Psychopharmacology. 2011;217:419\u201332.","journal-title":"Psychopharmacology"},{"key":"1257_CR41","doi-asserted-by":"publisher","first-page":"18465","DOI":"10.1073\/pnas.1109353108","volume":"108","author":"KL Simpson","year":"2011","unstructured":"Simpson KL, Weaver KJ, de Villers-Sidani E, Lu JY-F, Cai Z, Pang Y, et al. Perinatal antidepressant exposure alters cortical network function in rodents. Proc Natl Acad Sci U S A. 2011;108:18465\u201370.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"1257_CR42","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s12640-009-9022-4","volume":"15","author":"L-J Lee","year":"2009","unstructured":"Lee L-J. Neonatal fluoxetine exposure affects the neuronal structure in the somatosensory cortex and somatosensory-related behaviors in adolescent rats. Neurotox Res. 2009;15:212\u201323.","journal-title":"Neurotox Res"},{"key":"1257_CR43","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/brainsci9090235","volume":"9","author":"CE Creeley","year":"2019","unstructured":"Creeley CE, Denton LK. Use of prescribed psychotropics during pregnancy: a systematic review of pregnancy, neonatal, and childhood outcomes. Brain Sci. 2019;9:235.","journal-title":"Brain Sci"},{"key":"1257_CR44","first-page":"1","volume-title":"Antidepressants: pharmacology, health effects and controversy","author":"M Galbally","year":"2012","unstructured":"Galbally M, Lewis AJ, Gentile S. The biology of fetal exposure to serotonin reuptake inhibitors: implications for neurodevelopment. In: Migne IJ, Post JW, editors. Antidepressants: pharmacology, health effects and controversy. New York (NY): Nova; 2012. p. 1\u201326."},{"key":"1257_CR45","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.reprotox.2011.09.004","volume":"32","author":"TW Sadler","year":"2011","unstructured":"Sadler TW. Selective serotonin reuptake inhibitors (SSRIs) and heart defects: potential mechanisms for the observed associations. Reprod Toxicol. 2011;32:484\u20139.","journal-title":"Reprod Toxicol"},{"key":"1257_CR46","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000072272","volume":"25","author":"T Vitalis","year":"2003","unstructured":"Vitalis T, Parnavelas JG. The role of serotonin in early cortical development. Dev Neurosci. 2003;25:245\u201356.","journal-title":"Dev Neurosci"},{"key":"1257_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013372","volume":"7","author":"A B\u00e9rard","year":"2017","unstructured":"B\u00e9rard A, Zhao J-P, Sheehy O. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort. BMJ Open. 2017;7: e013372.","journal-title":"BMJ Open"},{"key":"1257_CR48","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1017\/S0033291709992194","volume":"40","author":"M Reis","year":"2010","unstructured":"Reis M, K\u00e4ll\u00e9n B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med. 2010;40:1723\u201333.","journal-title":"Psychol Med"},{"key":"1257_CR49","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b3569","volume":"339","author":"LH Pedersen","year":"2009","unstructured":"Pedersen LH, Henriksen TB, Vestergaard M, Olsen J, Bech BH. Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ. 2009;339: b3569.","journal-title":"BMJ"},{"key":"1257_CR50","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/bdra.20327","volume":"79","author":"BAJ K\u00e4ll\u00e9n","year":"2007","unstructured":"K\u00e4ll\u00e9n BAJ, Otterblad OP. Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Res A Clin Mol Teratol. 2007;79:301\u20138.","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"1257_CR51","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/01.ede.0000239581.76793.ae","volume":"17","author":"P Wogelius","year":"2006","unstructured":"Wogelius P, N\u00f8rgaard M, Gislum M, Pedersen L, Munk E, Mortensen PB, et al. Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations. Epidemiology. 2006;17:701\u20134.","journal-title":"Epidemiology"},{"key":"1257_CR52","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1001\/jamapediatrics.2015.3356","volume":"170","author":"T Boukhris","year":"2016","unstructured":"Boukhris T, Sheehy O, Mottron L, B\u00e9rard A. Antidepressant use during pregnancy and the risk of autism spectrum disorder in children. JAMA Pediatr. 2016;170:117\u201324.","journal-title":"JAMA Pediatr"},{"key":"1257_CR53","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1056\/NEJMoa1301449","volume":"369","author":"A Hviid","year":"2013","unstructured":"Hviid A, Melbye M, Pasternak B. Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism. N Engl J Med. 2013;369:2406\u201315.","journal-title":"N Engl J Med"},{"key":"1257_CR54","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f2059","volume":"346","author":"D Rai","year":"2013","unstructured":"Rai D, Lee BK, Dalman C, Golding J, Lewis G, Magnusson C. Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ. 2013;346: f2059.","journal-title":"BMJ"},{"key":"1257_CR55","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1001\/archgenpsychiatry.2011.73","volume":"68","author":"LA Croen","year":"2011","unstructured":"Croen LA, Grether JK, Yoshida CK, Odouli R, Hendrick V. Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry. 2011;68:1104\u201312.","journal-title":"Arch Gen Psychiatry"},{"key":"1257_CR56","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j2350","volume":"357","author":"KKC Man","year":"2017","unstructured":"Man KKC, Chan EW, Ip P, Coghill D, Simonoff E, Chan PKL, et al. Prenatal antidepressant use and risk of attention-deficit\/hyperactivity disorder in offspring: population based cohort study. BMJ. 2017;357: j2350.","journal-title":"BMJ"},{"key":"1257_CR57","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/jama.2017.3413","volume":"317","author":"AC Sujan","year":"2017","unstructured":"Sujan AC, Rickert ME, \u00d6berg AS, Quinn PD, Hern\u00e1ndez-D\u00edaz S, Almqvist C, et al. Associations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit\/hyperactivity disorder in offspring. JAMA. 2017;317:1553\u201362.","journal-title":"JAMA"},{"key":"1257_CR58","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/mp.2014.90","volume":"20","author":"CC Clements","year":"2015","unstructured":"Clements CC, Castro VM, Blumenthal SR, Rosenfield HR, Murphy SN, Fava M, et al. Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system. Mol Psychiatry. 2015;20:727\u201334.","journal-title":"Mol Psychiatry"},{"key":"1257_CR59","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/DBP.0b013e3181e5ac93","volume":"31","author":"R Figueroa","year":"2010","unstructured":"Figueroa R. Use of antidepressants during pregnancy and risk of attention-deficit\/hyperactivity disorder in the offspring. J Dev Behav Pediatr. 2010;31:641\u20138.","journal-title":"J Dev Behav Pediatr"},{"key":"1257_CR60","first-page":"1","volume":"216","author":"M McDonagh","year":"2014","unstructured":"McDonagh M, Matthews A, Phillipi C, Romm J, Peterson K, Thakurta S, et al. Antidepressant treatment of depression during pregnancy and the postpartum period. Evid Rep Technol Assess (Full Rep). 2014;216:1\u2013308.","journal-title":"Evid Rep Technol Assess (Full Rep)."},{"key":"1257_CR61","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/AOG.0000000000000410","volume":"124","author":"MS McDonagh","year":"2014","unstructured":"McDonagh MS, Matthews A, Phillipi C, Romm J, Peterson K, Thakurta S, et al. Depression drug treatment outcomes in pregnancy and the postpartum period: a systematic review and meta-analysis. Obstet Gynecol. 2014;124:526\u201334.","journal-title":"Obstet Gynecol"},{"key":"1257_CR62","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/jcpp.13004","volume":"60","author":"AC Sujan","year":"2019","unstructured":"Sujan AC, \u00d6berg AS, Quinn PD, D\u2019Onofrio BM. Annual research review: maternal antidepressant use during pregnancy and offspring neurodevelopmental problems - a critical review and recommendations for future research. J Child Psychol Psychiatry. 2019;60:356\u201376.","journal-title":"J Child Psychol Psychiatry"},{"key":"1257_CR63","doi-asserted-by":"publisher","first-page":"e1052","DOI":"10.4088\/JCP.17f11916","volume":"78","author":"C Andrade","year":"2017","unstructured":"Andrade C. Antidepressant exposure during pregnancy and risk of autism in the offspring, 2: do the new studies add anything new? J Clin Psychiatry. 2017;78:e1052\u20136.","journal-title":"J Clin Psychiatry"},{"key":"1257_CR64","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.4088\/JCP.22f14388","volume":"83","author":"C Andrade","year":"2022","unstructured":"Andrade C. Gestational exposure to antidepressant drugs and neurodevelopment: an examination of language, mathematics, intelligence, and other cognitive outcomes. J Clin Psychiatry. 2022;83:2288.","journal-title":"J Clin Psychiatry"},{"key":"1257_CR65","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.2174\/1570159X18666201015161105","volume":"19","author":"G Koren","year":"2021","unstructured":"Koren G, Ornoy A. Gestational exposure to serotonin reuptake inhibitors and pregnancy outcome; exploring the role of bias and confounders. Curr Neuropharmacol. 2021;19:2227\u201332.","journal-title":"Curr Neuropharmacol"},{"key":"1257_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.555740","volume":"11","author":"O Kapra","year":"2020","unstructured":"Kapra O, Rotem R, Gross R. The association between prenatal exposure to antidepressants and autism: some research and public health aspects. Front Psychiatry. 2020;11: 555740.","journal-title":"Front Psychiatry."},{"key":"1257_CR67","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1176\/appi.ajp.2020.20040418","volume":"177","author":"SE Maloney","year":"2020","unstructured":"Maloney SE, Rogers CE, Constantino JN. Antidepressants, pregnancy, and autism: setting the record(s) straight. Am J Psychiatry. 2020;177:479\u201381.","journal-title":"Am J Psychiatry"},{"key":"1257_CR68","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1001\/jamapsychiatry.2019.2193","volume":"76","author":"JM Flores","year":"2019","unstructured":"Flores JM, Avila-Quintero VJ, Bloch MH. Selective serotonin reuptake inhibitor use during pregnancy-associated with but not causative of autism in offspring. JAMA Psychiat. 2019;76:1225\u20137.","journal-title":"JAMA Psychiat"},{"key":"1257_CR69","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.euroneuro.2021.01.003","volume":"44","author":"M Lemelin","year":"2021","unstructured":"Lemelin M, Sheehy O, Zhao J-P, B\u00e9rard A. Maternal ADHD medication use during pregnancy and the risk of ADHD in children: importance of genetic predispositions and impact of using a sibling analysis. Eur Neuropsychopharmacol. 2021;44:66\u201378.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1257_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181042","volume":"12","author":"RE Brandlistuen","year":"2017","unstructured":"Brandlistuen RE, Ystrom E, Hernandez-Diaz S, Skurtveit S, Selmer R, Handal M, et al. Association of prenatal exposure to benzodiazepines and child internalizing problems: a sibling-controlled cohort study. PLoS ONE. 2017;12: e0181042.","journal-title":"PLoS ONE"},{"key":"1257_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/jcv2.12020","volume":"1","author":"K Gustavson","year":"2021","unstructured":"Gustavson K, Ystrom E, Ask H, Ask Torvik F, Hornig M, Susser E, et al. Acetaminophen use during pregnancy and offspring attention deficit hyperactivity disorder: a longitudinal sibling control study. JCPP Advances. 2021;1: e12020.","journal-title":"JCPP Advances."},{"key":"1257_CR72","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1093\/ije\/dyt183","volume":"42","author":"RE Brandlistuen","year":"2013","unstructured":"Brandlistuen RE, Ystrom E, Nulman I, Koren G, Nordeng H. Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study. Int J Epidemiol. 2013;42:1702\u201313.","journal-title":"Int J Epidemiol"},{"key":"1257_CR73","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s10519-014-9668-4","volume":"44","author":"R Kuja-Halkola","year":"2014","unstructured":"Kuja-Halkola R, D\u2019Onofrio BM, Larsson H, Lichtenstein P. Maternal smoking during pregnancy and adverse outcomes in offspring: genetic and environmental sources of covariance. Behav Genet. 2014;44:456\u201367.","journal-title":"Behav Genet"},{"key":"1257_CR74","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/ije\/dyq185","volume":"40","author":"C Obel","year":"2010","unstructured":"Obel C, Olsen J, Henriksen TB, Rodriguez A, J\u00e4rvelin M-R, Moilanen I, et al. Is maternal smoking during pregnancy a risk factor for hyperkinetic disorder? Findings from a sibling design. Int J Epidemiol. 2010;40:338\u201345.","journal-title":"Int J Epidemiol"},{"key":"1257_CR75","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/ije\/dyx067","volume":"46","author":"EM Eilertsen","year":"2017","unstructured":"Eilertsen EM, Gjerde LC, Reichborn-Kjennerud T, \u00d8rstavik RE, Knudsen GP, Stoltenberg C, et al. Maternal alcohol use during pregnancy and offspring attention-deficit hyperactivity disorder (ADHD): a prospective sibling control study. Int J Epidemiol. 2017;46:1633\u201340.","journal-title":"Int J Epidemiol"},{"key":"1257_CR76","doi-asserted-by":"publisher","first-page":"896","DOI":"10.2174\/1570159X19666210303121059","volume":"19","author":"R Leshem","year":"2021","unstructured":"Leshem R, Bar-Oz B, Diav-Citrin O, Gbaly S, Soliman J, Renoux C, et al. Selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) during pregnancy and the risk for autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) in the offspring: a true effect or a bias? A systematic review and meta-analysis. Curr Neuropharmacol. 2021;19:896\u2013906.","journal-title":"Curr Neuropharmacol"},{"key":"1257_CR77","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.4088\/JCP.19r12965","volume":"81","author":"A-S Rommel","year":"2020","unstructured":"Rommel A-S, Bergink V, Liu X, Munk-Olsen T, Molenaar NM. Long-term effects of intrauterine exposure to antidepressants on physical, neurodevelopmental, and psychiatric outcomes: a systematic review. J Clin Psychiatry. 2020;81:1965.","journal-title":"J Clin Psychiatry"},{"key":"1257_CR78","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1176\/appi.ajp.2020.18070766","volume":"177","author":"ML Vega","year":"2020","unstructured":"Vega ML, Newport GC, Bozhdaraj D, Saltz SB, Nemeroff CB, Newport DJ. Implementation of advanced methods for reproductive pharmacovigilance in autism: a meta-analysis of the effects of prenatal antidepressant exposure. Am J Psychiatry. 2020;177:506\u201317.","journal-title":"Am J Psychiatry"},{"key":"1257_CR79","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/acps.13030","volume":"139","author":"A Halvorsen","year":"2019","unstructured":"Halvorsen A, Hesel B, \u00d8stergaard SD, Danielsen AA. In utero exposure to selective serotonin reuptake inhibitors and development of mental disorders: a systematic review and meta-analysis. Acta Psych Scand. 2019;139:493\u2013507.","journal-title":"Acta Psych Scand."},{"key":"1257_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2017.12.007","volume":"86","author":"KKC Man","year":"2018","unstructured":"Man KKC, Chan EW, Ip P, Coghill D, Simonoff E, Chan PKL, et al. Prenatal antidepressant exposure and the risk of attention-deficit hyperactivity disorder in children: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2018;86:1\u201311.","journal-title":"Neurosci Biobehav Rev"},{"key":"1257_CR81","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/EDE.0000000000001494","volume":"33","author":"B\u00d6 Esen","year":"2022","unstructured":"Esen B\u00d6, Ehrenstein V, S\u00f8rensen HT, Laugesen K, Pedersen L. Prenatal antidepressant exposure and the risk of attention-deficit\/hyperactivity disorder in childhood: a cohort study with triangulation. Epidemiology. 2022;33:581\u201392.","journal-title":"Epidemiology"},{"key":"1257_CR82","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/wps.20948","volume":"21","author":"Z Wang","year":"2022","unstructured":"Wang Z, Chan AYL, Ho PWH, Wong KHTW, Brauer R, Besag FMC, et al. Prenatal exposure to antidepressants or antipsychotics and the risk of seizure in children. World Psychiatry. 2022;21:322\u20133.","journal-title":"World Psychiatry"},{"key":"1257_CR83","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1001\/jama.2021.17380","volume":"326","author":"J Christensen","year":"2021","unstructured":"Christensen J, Trabjerg BB, Sun Y, Dreier JW. Association of maternal antidepressant prescription during pregnancy with standardized test scores of Danish school-aged children. JAMA. 2021;326:1725\u201335.","journal-title":"JAMA"},{"key":"1257_CR84","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.2147\/CLEP.S180618","volume":"10","author":"KW Hagberg","year":"2018","unstructured":"Hagberg KW, Robijn AL, Jick S. Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring. Clin Epidemiol. 2018;10:1599\u2013612.","journal-title":"Clin Epidemiol"},{"key":"1257_CR85","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/ije\/dyv351","volume":"45","author":"A Viktorin","year":"2016","unstructured":"Viktorin A, Lichtenstein P, Lundholm C, Almqvist C, D\u2019Onofrio BM, Larsson H, et al. Selective serotonin re-uptake inhibitor use during pregnancy: association with offspring birth size and gestational age. Int J Epidemiol. 2016;45:170\u20137.","journal-title":"Int J Epidemiol"},{"key":"1257_CR86","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1798","volume":"350","author":"K Furu","year":"2015","unstructured":"Furu K, Kieler H, Haglund B, Engeland A, Selmer R, Stephansson O, et al. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design. BMJ. 2015;350: h1798.","journal-title":"BMJ"},{"key":"1257_CR87","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1001\/jama.2017.3415","volume":"317","author":"HK Brown","year":"2017","unstructured":"Brown HK, Ray JG, Wilton AS, Lunsky Y, Gomes T, Vigod SN. Association between serotonergic antidepressant use during pregnancy and autism spectrum disorder in children. JAMA. 2017;317:1544\u201352.","journal-title":"JAMA"},{"key":"1257_CR88","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1136\/bmj.j2811","volume":"358","author":"D Rai","year":"2017","unstructured":"Rai D, Lee BK, Dalman C, Newschaffer C, Lewis G, Magnusson C. Antidepressants during pregnancy and autism in offspring: population based cohort study. BMJ. 2017;358:2811.","journal-title":"BMJ"},{"key":"1257_CR89","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S53009","volume":"5","author":"MJ S\u00f8rensen","year":"2013","unstructured":"S\u00f8rensen MJ, Gr\u00f8nborg TK, Christensen J, Parner ET, Vestergaard M, Schendel D, et al. Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clin Epidemiol. 2013;5:449\u201359.","journal-title":"Clin Epidemiol"},{"key":"1257_CR90","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003507","volume":"3","author":"K Laugesen","year":"2013","unstructured":"Laugesen K, Olsen MS, Tel\u00e9n Andersen AB, Fr\u00f8slev T, Toft SH. In utero exposure to antidepressant drugs and risk of attention deficit hyperactivity disorder: a nationwide Danish cohort study. BMJ Open. 2013;3: e003507.","journal-title":"BMJ Open"},{"key":"1257_CR91","doi-asserted-by":"publisher","first-page":"e842","DOI":"10.4088\/JCP.14m09240","volume":"76","author":"I Nulman","year":"2015","unstructured":"Nulman I, Koren G, Rovet J, Barrera M, Streiner DL, Feldman BM. Neurodevelopment of children prenatally exposed to selective reuptake inhibitor antidepressants: Toronto sibling study. J Clin Psychiatry. 2015;76:e842\u20137.","journal-title":"J Clin Psychiatry"},{"key":"1257_CR92","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/ije\/dyv030","volume":"44","author":"RE Brandlistuen","year":"2015","unstructured":"Brandlistuen RE, Ystrom E, Eberhard-Gran M, Nulman I, Koren G, Nordeng H. Behavioural effects of fetal antidepressant exposure in a Norwegian cohort of discordant siblings. Int J Epidemiol. 2015;44:1397\u2013407.","journal-title":"Int J Epidemiol"},{"key":"1257_CR93","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1093\/ije\/dyz170","volume":"48","author":"JM Cohen","year":"2019","unstructured":"Cohen JM, Wood ME, Hern\u00e1ndez-D\u00edaz S, Ystrom E, Nordeng H. Paternal antidepressant use as a negative control for maternal use: assessing familial confounding on gestational length and anxiety traits in offspring. Int J Epidemiol. 2019;48:1665\u201372.","journal-title":"Int J Epidemiol"},{"key":"1257_CR94","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00228-006-0177-0","volume":"62","author":"T Ververs","year":"2006","unstructured":"Ververs T, Kaasenbrood H, Visser G, Schobben F, de Jong-van den Berg L, Egberts T. Prevalence and patterns of antidepressant drug use during pregnancy. Eur J Clin Pharmacol. 2006;62:863\u201370.","journal-title":"Eur J Clin Pharmacol."},{"key":"1257_CR95","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2147\/CLEP.S156210","volume":"10","author":"A Lupattelli","year":"2018","unstructured":"Lupattelli A, Twigg MJ, Zagorodnikova K, Moretti ME, Drozd M, Panchaud A, et al. Self-reported perinatal depressive symptoms and postnatal symptom severity after treatment with antidepressants in pregnancy: a cross-sectional study across 12 European countries using the Edinburgh Postnatal Depression Scale. Clin Epidemiol. 2018;10:655\u20139.","journal-title":"Clin Epidemiol"},{"key":"1257_CR96","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00737-016-0629-1","volume":"19","author":"L Underwood","year":"2016","unstructured":"Underwood L, Waldie K, D\u2019Souza S, Peterson ER, Morton S. A review of longitudinal studies on antenatal and postnatal depression. Arch Womens Ment Health. 2016;19:711\u201320.","journal-title":"Arch Womens Ment Health"},{"key":"1257_CR97","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s10995-016-2191-x","volume":"21","author":"L Underwood","year":"2017","unstructured":"Underwood L, Waldie KE, D\u2019Souza S, Peterson ER, Morton SMB. A longitudinal study of pre-pregnancy and pregnancy risk factors associated with antenatal and postnatal symptoms of depression: evidence from growing up in New Zealand. Matern Child Health J. 2017;21:915\u201331.","journal-title":"Matern Child Health J"},{"key":"1257_CR98","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/imhj.21450","volume":"35","author":"E Lefkovics","year":"2014","unstructured":"Lefkovics E, Baji I, Rig\u00f3 J. Impact of maternal deprssion on pregnancies and on early attachment. Infant Ment Health J. 2014;35:354\u201365.","journal-title":"Infant Ment Health J"},{"key":"1257_CR99","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00737-003-0024-6","volume":"6","author":"SL Grace","year":"2003","unstructured":"Grace SL, Evindar A, Stewart DE. The effect of postpartum depression on child cognitive development and behavior: a review and critical analysis of the literature. Arch Womens Ment Health. 2003;6:263\u201374.","journal-title":"Arch Womens Ment Health"},{"key":"1257_CR100","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0883-9417(98)80004-6","volume":"12","author":"CT Beck","year":"1998","unstructured":"Beck CT. The effects of postpartum depression on child development: a meta-analysis. Arch Psychiatr Nurs. 1998;12:12\u201320.","journal-title":"Arch Psychiatr Nurs"},{"key":"1257_CR101","first-page":"19134","volume":"81","author":"H Bayrampour","year":"2020","unstructured":"Bayrampour H, Kapoor A, Bunka M, Ryan D. The risk of relapse of depression during pregnancy after discontinuation of antidepressants: a systematic review and meta-analysis. J Clin Psych. 2020;81:19134.","journal-title":"J Clin Psych"},{"key":"1257_CR102","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1097\/AOG.0b013e31823294da","volume":"118","author":"CL Palladino","year":"2011","unstructured":"Palladino CL, Singh V, Campbell J, Flynn H, Gold KJ. Homicide and suicide during the perinatal period: findings from the National Violent Death Reporting System. Obstet Gynecol. 2011;118:1056\u201363.","journal-title":"Obstet Gynecol"},{"key":"1257_CR103","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/jama.1997.03540280071036","volume":"277","author":"RMA Hirschfeld","year":"1997","unstructured":"Hirschfeld RMA, Keller MB, Panico S, Arons BS, Barlow D, Davidoff F, et al. The national depressive and manic-depressive association consensus statement on the undertreatment of depression. JAMA. 1997;277:333\u201340.","journal-title":"JAMA"},{"key":"1257_CR104","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.4088\/JCP.08m04943","volume":"70","author":"RJ Valuck","year":"2009","unstructured":"Valuck RJ, Orton HD, Libby AM. Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case-control study. J Clin Psych. 2009;70:1069\u201377.","journal-title":"J Clin Psych"},{"key":"1257_CR105","first-page":"13560","volume":"2","author":"JV Brown","year":"2021","unstructured":"Brown JV, Wilson CA, Ayre K, Robertson L, South E, Molyneaux E, et al. Antidepressant treatment for postnatal depression. Cochrane Database Syst Rev. 2021;2:13560.","journal-title":"Cochrane Database Syst Rev"},{"key":"1257_CR106","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/acps.13367","volume":"145","author":"A Kautzky","year":"2022","unstructured":"Kautzky A, Slamanig R, Unger A, H\u00f6flich A. Neonatal outcome and adaption after in utero exposure to antidepressants: a systematic review and meta-analysis. Acta Psychiatr Scand. 2022;145:6\u201328.","journal-title":"Acta Psychiatr Scand"},{"key":"1257_CR107","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1097\/AOG.0000000000004538","volume":"138","author":"R Vlenterie","year":"2021","unstructured":"Vlenterie R, van Gelder MMHJ, Anderson HR, Andersson L, Broekman BFP, Dubnov-Raz G, et al. Associations between maternal depression, antidepressant use during pregnancy, and adverse pregnancy outcomes: an individual participant data meta-analysis. Obstet Gynecol. 2021;138:633\u201346.","journal-title":"Obstet Gynecol"},{"key":"1257_CR108","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s40264-020-01027-x","volume":"44","author":"C De Vries","year":"2021","unstructured":"De Vries C, Gadzhanova S, Sykes MJ, Ward M, Roughead E. A systematic review and meta-analysis considering the risk for congenital heart defects of antidepressant classes and individual antidepressants. Drug Saf. 2021;44:291\u2013312.","journal-title":"Drug Saf"},{"key":"1257_CR109","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.neubiorev.2021.09.040","volume":"131","author":"MTY Leung","year":"2021","unstructured":"Leung MTY, Wong KH, Ho PWH, Ip P, Wei L, Wong ICK, et al. Gestational exposure to antidepressants and risk of seizure in offspring: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2021;131:345\u201359.","journal-title":"Neurosci Biobehav Rev"},{"issue":"57","key":"1257_CR110","first-page":"e1","volume":"220","author":"R Masarwa","year":"2019","unstructured":"Masarwa R, Bar-Oz B, Gorelik E, Reif S, Perlman A, Matok I. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis. Am J Obstet Gynecol. 2019;220(57):e1-13.","journal-title":"Am J Obstet Gynecol"},{"key":"1257_CR111","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12916-018-1193-5","volume":"16","author":"S-Y Gao","year":"2018","unstructured":"Gao S-Y, Wu Q-J, Sun C, Zhang T-N, Shen Z-Q, Liu C-X, et al. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births. BMC Med. 2018;16:205.","journal-title":"BMC Med"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-022-01257-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-022-01257-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-022-01257-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T16:04:54Z","timestamp":1682611494000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-022-01257-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,20]]},"references-count":111,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["1257"],"URL":"https:\/\/doi.org\/10.1007\/s40264-022-01257-1","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,20]]},"assertion":[{"value":"7 November 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received in relation to the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"The authors contributed equally to all stages of the review. The final manuscript was approved by both authors.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}